Filing Flows

Filing Flows › Lifecore Biomedical (LFCR) › Who owns the stock

Who owns Lifecore Biomedical (LFCR) stock

94 funds reported Lifecore Biomedical (LFCR) shares in their latest 13F filings, worth $147M in all. The largest holder is Wynnefield Capital ($24.7M). Last quarter 44 funds added to their stakes and 37 cut them.

Largest holders of LFCR (13F)Largest holders of LFCR (13F)Wynnefield Capital$24.7MLegion Partners Asset Management,…$23.4MGreenhaven Road Investment Manage…$16.8M325 Capital LLC$15.2MVanguard Group$13.7MBlackRock$10.6MVanguard Capital Management LLC$6.8MGeode Capital Management, LLC$4.5MMorgan Stanley$4.0MState Street$3.5M

Largest holders (13F)

FundSharesValueChangeQuarter
Wynnefield Capital4,703,216$24.7Munchanged2026-06-30
Legion Partners Asset Management, LLC4,461,823$23.4Munchanged2026-06-30
Greenhaven Road Investment Management, L.P.3,190,769$16.8Mdecrease2026-06-30
325 Capital LLC2,895,881$15.2Mincrease2026-06-30
Vanguard Group1,673,666$13.7Mincrease2025-12-31
BlackRock2,013,093$10.6Mincrease2026-06-30
Vanguard Capital Management LLC1,288,621$6.8Mdecrease2026-06-30
Geode Capital Management, LLC855,500$4.5Mincrease2026-06-30
Morgan Stanley769,360$4.0Mincrease2026-06-30
State Street668,031$3.5Mincrease2026-06-30
DCF Advisers, LLC376,500$2.5Mdecrease2026-09-30
Quinn Opportunity Partners LLC453,495$2.4Munchanged2026-06-30
Wittenberg Investment Management314,015$1.6Mincrease2026-06-30
Northern Trust253,817$1.3Mincrease2026-06-30
Vanguard Fiduciary Trust239,924$1.3Mincrease2026-06-30

Lifecore Biomedical's latest quarter

Lifecore Biomedical, Q1 FY27: revenue $25.3M (-19% year over year), operating margin -3.5%, net loss $40.1M, operating cash flow $6.9M. The chart follows the revenue to costs, profit and cash.

Questions

Who owns the most LFCR stock?

By the latest 13F filings: Wynnefield Capital ($24.7M); Legion Partners Asset Management, LLC ($23.4M); Greenhaven Road Investment Management, L.P. ($16.8M); 325 Capital LLC ($15.2M); Vanguard Group ($13.7M).

What is the short interest in LFCR?

1,803,186 shares were sold short at the 2026-10-15 settlement, -27.18% of the float.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.